Providing Ophthalmic Instruments and Accessories to the

Tampa—Sirion Therapeutics Inc. has made an exclusive licensing agreement with Laboratoires Thea of France for U.S. rights to develop and market a topical ophthalmic gel containing ganciclovir for treating certain viral and superficial eye infections. (Source: Ophthalmology Times - Ophthalmic News)